What’s New

Summit on Biologics and Biosimilars Tackles Choice, Switching & Patient Access

Physicians and patients are no longer asking if a biological medicine is the best choice, but – more likely – which biological medicine is the

Read More

***MEDIA ADVISORY*** Thursday Summit on Biologics & Biosimilars Convenes Physicians, Advocates and Officials to Discuss Policy Issues

Summit will explore policies impacting patient access to biologic and biosimilar medications  WASHINGTON – Tomorrow the Institute for Patient Access and Biologics Prescribers Collaborative, a project

Read More

***VIDEO PRESS RELEASE*** AfPA Releases New Video “The Interchangeability Promise”

Video released ahead of 2nd Annual National Policy and Advocacy Summit on Biologics and Biosimilars  WASHINGTON – Today the Alliance for Patient Access released a

Read More

***PRESS RELEASE*** Michigan Health Plans Reject Nearly Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations  WASHINGTON – The Institute for Patient Access released a new Health Plan

Read More

New AfPA Video Examines “The Interchangeability Promise”

First came biologics, then biosimilars.  And soon, explains a newly released video from The Alliance for Patient Access, patients can expect interchangeable biosimilars.  According to

Read More

***PRESS RELEASE*** Kentucky Health Plans Reject Nearly Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations WASHINGTON – The Institute for Patient Access released a new Health Plan

Read More

How to Achieve Hepatitis Elimination

Eliminating hepatitis B and C can be done, experts agree. And this week, a new report from the National Academies of Sciences, Engineering, and Medicine

Read More

*** PRESS RELEASE*** Summit on Biologics & Biosimilars Convenes Physicians, Advocates and Officials to Discuss Policy Issues

WASHINGTON – On Thursday, April 6 the Institute for Patient Access and Biologics Prescribers Collaborative, a project of the Alliance for Patient Access, will host

Read More

Access Worries Persist after ICER’s Arthritis Report, Meeting

A drug pricing watchdog group had its final say Friday on targeted arthritis treatments – and it may not be good news for patients. The

Read More

***PRESS RELEASE*** Georgia Health Plans Reject Half of Claims for High Cholesterol Treatment

New health plan report card analyzes PCSK9 inhibitor claims for managed care organizations WASHINGTON – The Institute for Patient Access released a new Health Plan

Read More
Back to Top